{"news_desk": "National", "print_page": "15", "section_name": "Health", "subsection_name": null, "byline": {"original": "By GINA KOLATA", "person": [{"rank": 1, "role": "reported", "firstname": "Gina", "organization": "", "lastname": "KOLATA"}]}, "abstract": "Advisory panel recommends that Food and Drug Admin approve evolocumab, second in new class of drugs that can drastically lower cholesterol levels; doctors hope drugs may help those at high risk of heart attack who are unable to control their conditions with statins.", "type_of_material": "News", "word_count": "890", "lead_paragraph": "Early results of clinical trials raised hopes that the therapies would be critical new additions to the treatment arsenal for those at risk of heart disease.", "pub_date": "2015-06-11T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Panel Tells F.D.A. to Back Second Drug to Help Heart ", "print_headline": "Panel Tells F.D.A. to Back Second Drug to Help Heart "}, "snippet": "Early results of clinical trials raised hopes that the therapies would be critical new additions to the treatment arsenal for those at risk of heart disease.", "multimedia": [{"height": 126, "url": "images/2015/06/11/science/11DRUG/11DRUG-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/06/11/science/11DRUG/11DRUG-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 400, "url": "images/2015/06/11/science/11DRUG/11DRUG-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2015/06/11/science/11DRUG/11DRUG-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/06/11/science/11DRUG/11DRUG-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/06/11/science/11DRUG/11DRUG-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/06/11/us/panel-tells-fda-to-back-second-drug-to-help-heart.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Heart", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "Cholesterol", "name": "subject"}, {"rank": "3", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "4", "is_major": "Y", "value": "Food and Drug Administration", "name": "organizations"}, {"rank": "5", "is_major": "N", "value": "Statins (Cholesterol-Lowering Drugs)", "name": "subject"}], "blog": [], "_id": "5578e2ce38f0d808b502d37f", "source": "The New York Times"}